Invesco, LLC Dexcom Inc Transaction History

Invesco, LLC

  • $251 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$114.22 - $140.1 $18,275 - $22,416
-160 Reduced 9.73%
1,484 $206 Million
Q4 2023

Jan 30, 2024
BUY
$75.49 - $124.16 $124,105 - $204,119
1,644 New
1,644 $204 Million
Q2 2023

Aug 15, 2023
BUY
$112.47 - $130.98 $305,018 - $355,217
2,712 New
2,712 $349 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Invesco, LLC Portfolio

Follow Invesco, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invesco, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email